NEW YORK, July 10, 2012 /PRNewswire/ -- Intellipharmaceutics International Inc. (Nasdaq: IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that Shameze Rampertab, B.Sc., MBA, CA, Vice President Finance and Chief Financial Officer, will present at RetailInvestorConferences.com.
DATE: July 12, 2012
TIME: 1:00 PM EDT
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register to save time and receive event updates.
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics has a pipeline of product candidates in various stages of development, including six ANDAs under review by the FDA, in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes, pain and infection.
Certain statements in this document and upcoming presentation and webc
|SOURCE Intellipharmaceutics International Inc.|
Copyright©2012 PR Newswire.
All rights reserved